Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Aciclovir Menarini Brand

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 619Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of February 18, 2026
    Enforcement Report - Week of February 18, 2026

    18 Feb 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-18-2026-14056.pdf

    FDA
    18 Feb 2026
    Share Share
    Ddreg Pharma's Generic Acyclovir Sodium Receives Approval in US
    Ddreg Pharma's Generic Acyclovir Sodium Receives Approval in US

    25 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215404

    FDA
    25 Jun 2024
    Share Share
    Hainan Poly's Generic Acyclovir Sodium Receives Approval in the U.S.
    Hainan Poly's Generic Acyclovir Sodium Receives Approval in the U.S.

    08 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218111

    FDA
    08 Jan 2024
    Share Share
    Enforcement Report - Week of January 11, 2023
    Enforcement Report - Week of January 11, 2023

    11 Jan 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-11-2023-52259.pdf

    FDA
    11 Jan 2023
    Share Share
    Enforcement Report - Week of October 26, 2022
    Enforcement Report - Week of October 26, 2022

    26 Oct 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-26-2022-89071.pdf

    FDA
    26 Oct 2022
    Share Share
    Eugia US LLC Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection 500 mg per 10 mL
    Eugia US LLC Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection 500 mg per 10 mL

    28 Sep 2022

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-issues-voluntary-nationwide-recall-acyclovir-sodium-injection-500-mg-10-ml-50-mgml-due

    FDA
    28 Sep 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.